Literature DB >> 1352773

A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps).

H Schweitz1, P Vigne, D Moinier, C Frelin, M Lazdunski.   

Abstract

This paper describes the purification, sequence, and biological properties of a 38-amino acid residue peptide from the venom of Dendroaspis angusticeps which shared important sequence homologies with natriuretic peptides. Dendroaspis natriuretic peptide (DNP) relaxed aortic strips that had been contracted by 40 mM KCl with a potency (K0.5 = 20 nM) similar to that of atrial natriuretic peptide (ANP) and larger than that of C type natriuretic peptide (CNP). The relaxing actions of ANP and DNP (both at 100 nM) were mutually exclusive. Bovine aortic endothelial cells responded to ANP (K0.5 = 3 nM) and DNP (K0.5 = 3 nM) but not to CNP by a large activation of guanylate cyclase. Rat aortic myocytes showed larger cGMP responses to CNP (K0.5 = 10 nM) than to ANP or DNP (K0.5 = 100 nM). Finally, DNP completely prevented the specific 125I-ANP binding to clearance receptors in cultured aortic myocytes with a potency (Kd = 10 nM) that was less than that of ANP (Kd = 0.3 nM). It is concluded that DNP is a new member of the family of natriuretic peptides and that it recognizes ANPA receptors and clearance, ANPc receptors, but not CNP-specific ANPB receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1352773

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  61 in total

Review 1.  Vasopeptidase inhibition: a new direction in cardiovascular treatment.

Authors:  J R Asher; A J Naftilan
Journal:  Curr Hypertens Rep       Date:  2000-08       Impact factor: 5.369

2.  Defensin-like peptide-2 from platypus venom: member of a class of peptides with a distinct structural fold.

Authors:  A M Torres; G M de Plater; M Doverskog; L C Birinyi-Strachan; G M Nicholson; C H Gallagher; P W Kuchel
Journal:  Biochem J       Date:  2000-06-15       Impact factor: 3.857

Review 3.  Novel natriuretic peptides: new compounds and new approaches.

Authors:  Mark W Vogel; Horng H Chen
Journal:  Curr Heart Fail Rep       Date:  2011-03

Review 4.  Host Peptidic Hormones Affecting Bacterial Biofilm Formation and Virulence.

Authors:  Olivier Lesouhaitier; Thomas Clamens; Thibaut Rosay; Florie Desriac; Mélissande Louis; Sophie Rodrigues; Andrei Gannesen; Vladimir K Plakunov; Emeline Bouffartigues; Ali Tahrioui; Alexis Bazire; Alain Dufour; Pierre Cornelis; Sylvie Chevalier; Marc G J Feuilloley
Journal:  J Innate Immun       Date:  2018-11-05       Impact factor: 7.349

5.  Reference values of NT-proBNP serum concentrations in the umbilical cord blood and in healthy neonates and children.

Authors:  L Schwachtgen; M Herrmann; T Georg; P Schwarz; N Marx; A Lindinger
Journal:  Z Kardiol       Date:  2005-06

6.  Intracerebroventricular administration of atrial natriuretic peptide prevents increase of plasma ADH, aldosterone and corticosterone levels in restrained conscious dehydrated rabbits.

Authors:  C Kallaras; N Angelopoulos; S Bountzioukas; K Mavroudis; M Karamouzis; O Guiba-Tziampiri
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

7.  Insulin-degrading enzyme modulates the natriuretic peptide-mediated signaling response.

Authors:  Luis A Ralat; Qing Guo; Min Ren; Todd Funke; Deborah M Dickey; Lincoln R Potter; Wei-Jen Tang
Journal:  J Biol Chem       Date:  2010-11-22       Impact factor: 5.157

Review 8.  Natriuretic peptide C receptor signalling in the heart and vasculature.

Authors:  Robert A Rose; Wayne R Giles
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 9.  Cyclic nucleotide regulation of cardiac sympatho-vagal responsiveness.

Authors:  Dan Li; David J Paterson
Journal:  J Physiol       Date:  2016-05-05       Impact factor: 5.182

Review 10.  Guanylyl cyclase / atrial natriuretic peptide receptor-A: role in the pathophysiology of cardiovascular regulation.

Authors:  Kailash N Pandey
Journal:  Can J Physiol Pharmacol       Date:  2011-08-04       Impact factor: 2.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.